Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott A. Gangloff currently holds 26,351 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott A. Gangloff has been a net seller of ONS stock. They have purchased $0 and sold $140.1K worth of shares.
Scott A. Gangloff's most recent insider trade was on Dec 9, 2025, when they sold 5,088 shares at $0.00 per share.
Scott A. Gangloff serves as Executive at Oncobiologics, Inc. (ONS). They have executed 10 insider transactions totaling $140.1K over their tenure at the company.
Scott A. Gangloff holds the position of Executive at Oncobiologics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Scott A. Gangloff has shown a selling trading pattern, with $0 in total purchases and $140.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott A. Gangloff was on Nov 11, 2016, when they sold $140.1K worth of ONS shares. This transaction involved 37,369 shares at $3.75 per share.
Scott A. Gangloff currently owns 26,351 shares of Oncobiologics, Inc. (ONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott A. Gangloff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott A. Gangloff has 10 Form 4 filings on record as an insider at Oncobiologics, Inc..
Set alerts for Scott A. Gangloff and 40,000+ other insiders.